In the U.S., when the topic of clean energy comes up, we like to debate concepts like climate change or global warming, turning it into a political debate more than a strategic one. Subsidies to industries such as wind or solar, no matter how small, take criticism from politicians and the media while the government continues to subsidizes oil, gas, coal, and nuclear production to the tune of billions of dollars each year. We neglect to account for externalities such as the cost of war ships keeping the Suez Canal open when Iran threatens to close it, oil spills inland and offshore, the wars in Iraq, and the limited liability given to the operators' nuclear plants. If Fukishima happened here, it would be no problem for U.S. companies -- Uncle Sam would pick up the tab.
In China, the energy debate is very different. When China sees its imports of coal rising and dependence on foreign oil growing, it springs into action. Not by screaming, "Drill, baby, drill," but by investing billions of dollars in home-grown energy sources. Yes, I'm talking about clean, renewable energy, and China's investment in these energy sources make U.S. subsidies look like the half-hearted effort they are.
Top 10 Consumer Service Stocks To Invest In Right Now: Sutor Technology Group Ltd (SUTR)
Sutor Technology Group Limited, incorporated on May 1, 1997, manufacture fine finished steel products. The Company utilizes a range of processes and technological methodologies to converts steel manufactured by third parties into fine finished steel products. The Company's product offerings are focused on finished steel products, specifically hot-dip galvanized steel (HDG steel), and pre-painted galvanized steel, or PPGI. In addition, the Company produces acid pickled steel (AP steel), and cold-rolled steel. The Company's three operating segments are categorized according to the Company's three operating subsidiaries, which include Changshu Huaye, which manufactures and sells HDG steel and PPGI products; Jiangsu Cold-Rolled, which manufactures and sells HDG steel, AP steel and cold-rolled steel, and Ningbo Zhehua, which manufactures and sells welded steel pipe products.
The Company sells its products to customers who operate primarily in the solar energy, appliances, automobile, construction, infrastructure, medical equipment and water resource industries. The Company's primary export markets are Europe, the Middle East, Asia, and South America. The Company's manufacturing facilities, located in Changshu, China, have three HDG steel production lines, one PPGI production line, one AP steel production line and one cold-rolled steel line. The Company's products include HDG steel, PPGI, AP steel, cold-rolled steel and welded steel pipe products. The Company's HDG steel and PPGI products are primarily manufactured by Changshu Huaye and the Company's AP steel and cold-rolled steel products are primarily manufactured by Jiangsu Cold-Rolled.
HDG Steel
The Company manufactures corrosion-resistant and zinc-coated HDG steel in different dimensions and using different materials and specifications by its customers. HDG steel products are manufactured from steel substrate of cold-rolled or hot-rolled pickled coils by applying zinc to the surface of the material to enhance its! corrosion protection. HDG steel products are principally used in the electrical household appliances and construction markets. Sales of HDG steel products amounted to approximately 451,269 MT in fiscal year 2012, representing approximately 63.8% of the Company's total revenue. The Company's HDG steel products are manufactured by Changshu Huaye and Jiangsu Cold-Rolled. Changshu Huaye produces only HDG of cold-rolled steel.
PPGI Products
PPGI products are made to order based on customer specifications. The Company's PPGI products��specification generally ranges from 700mm to 1250mm in width and from 0.2mm to 1.2mm in thickness. The Company's PPGI products are used in solar energy, appliances and construction materials. The Company produces its PPGI by color-coating on HDG of cold-rolled steel and then coating them in various colors according to customer requirements. The Company's PPGI production line is equipped with the twice baking and coating technology, which together with indirect heating, enhances the color coated layers adhesion to the galvanized zinc layer.
AP Steel
Acid pickling is a process that removes scales and oxides from the steel surface by pickling, cold rolling and annealing. AP steel products are used as a raw material for cold-rolled steel strip, HDG steel, as well as components of automobile and manufacturing equipment. AP steel products come in several different dimensions and using different materials and different specifications.
Full-Hard, Cold-rolled Steel Products
Full-hard cold-rolled steel strips are treated in an annealing process and are used to produce HDG of cold-rolled steel. The Company produces full-hard cold-rolled steel strips through a reverse cold rolling mill.
Welded Steel Pipe Products
The Company's subsidiary Ningbo Zhehua has one advanced Joint Center of Excellence (JCOE) production line for large-diameter, double-side, submerged-arc welded steel pipes, t! hree US L! incoln production lines for spiral seam, double-side, submerged-arc welded steel pipes, and two REF production lines for roll-bending, double-side, submerged-arc welded steel pipes. Ningbo Zhehua is specialized in manufacturing large-diameter, double-side, submerged-arc welded steel pipes and spiral seam steel pipes. The finished products are used for oil and gas transmission, municipal water supply projects, sewage treatment projects, and piling.
The Company competes with ArcelorMittal and Posco Steel.
Advisors' Opinion:- [By Monica Gerson]
Sutor Technology Group (NASDAQ: SUTR) is projected to report its Q4 earnings at $0.10 per share on revenue of $152.96 million.
Le Gaga Holdings (NASDAQ: GAGA) is estimated to report its Q4 earnings.
- [By James E. Brumley]
To tell the truth, I had almost forgotten about Sutor Technology Group Ltd. (NASDAQ:SUTR) after posting my "right stock, wrong time" speech back on the 9th. While I loved the way SUTR had broken past a horizontal ceiling at $1.83 after several weeks' worth of trying, the bullish move itself was a little overheated and looked like it was setting up a near-term pullback. Only after that dip would the stock be a healthy buy again.
Top Clean Energy Stocks To Own For 2014: Kansas City Southern (KSU)
Kansas City Southern, through its subsidiaries, engages primarily in the freight rail transportation business. It operates north/south rail between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States. The company also operates direct rail passageway between Mexico City and Laredo in Texas, serving various Mexico?s industrial cities and 3 of its shipping ports; and a 157-mile rail line extending from Laredo, Texas to the port city of Corpus Christi, Texas, as well as owns the northern half of the rail bridge at Laredo, Texas. In addition, Kansas City Southern holds a concession to operate a 47-mile railroad located adjacent to the Panama Canal, as well as operates and promotes commuter and tourist passenger services. Further, the company operates a bulk materials handling facility with deep-water access to the Gulf of Mexico at Port Arthur, Texas that stores and transfers petroleum coke from rail cars to ships primarily for export; and a railroad wood tie treatment facility. It serves customers conducting business in various industries, including electric-generating utilities, chemical and petroleum products, industrial and consumer products, agriculture and mineral products, automotive products, and intermodal freight transportation. The company was formerly known as Kansas City Southern Industries, Inc. and changed its name to Kansas City Southern in 2002. Kansas City Southern was founded in 1962 and is based in Kansas City, Missouri.
Advisors' Opinion:- [By Ben Levisohn]
Investors have created a monster of their own–the emerging markets, an amalgamation of various countries that have very little in common–and like the monster in the original Frankenstein, they’re coming for their creator. The iShares MSCI Emerging Markets ETF (EEM) fell 3.9% to $38.24 this week–dragging down U.S. stocks with it. The S&P 500 fell 2.6% to 1,790.29, its largest one-week decline since June, 2012, as it was pulled lower by International Game Technology (IGT) and Kansas City Southern (KSU). The Dow Jones Industrial Average fell 3.5% to 15,879.11, its largest decline since November, 2011, with�EI Du Pont De Nemours (DD) and�General Electric (GE) the biggest losers. The 10-year Treasury yield fell to 2.726%, down from 3.006% at the start of 2014, as investors flocked to the relative safety of bonds.
Top Clean Energy Stocks To Own For 2014: Pharmacyclics Inc (PCYC)
Pharmacyclics, Inc., incorporated on April 19, 1991, is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved in human diseases. As of June 30, 2011, it had three drug candidates under clinical development and a number of preclinical lead molecules. This includes an inhibitor of Bruton�� tyrosine kinase (Btk) (PCI-32765) in Phase II studies in hematologic malignancies; a Btk inhibitor lead optimization program targeting autoimmune indications, an inhibitor of Factor VIIa (PCI-27483) in a Phase II clinical trial in pancreatic cancer, and a histone deacetylase (HDAC) inhibitor (PCI-24781) in Phase I and II clinical trials in solid tumors and hematological malignancies as of June 30, 2012.
As of June 30, 2012, the Company developed ibrutinib, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a variety of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse B-cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its current or planned Phase Ib/II and Phase III development program. had development programs for B-cell malignancies and autoimmune diseases. For malignant indications it has developed PCI-32765, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a range of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its Phase II development. It has developed an assay! to measure occupancy of Btk in PBMCs using a cell-permeable fluorescently-labeled derivative of PCI-32765.
Factor VII is an enzyme that becomes activated (FVIIa) by binding to the cell surface protein tissue factor (TF), a protein found in the body that helps to trigger the process of blood clotting in response to injury. TF is over expressed in many cancers including gastric, breast, colon, lung, prostate, ovarian and pancreatic cancers. In these tumors, the FVIIa/TF complex induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2), another cell-surface protein. This in turn increases the expression of interleukin-8 (IL-8), a protein produced by white blood cells and other immune cells in response to pathogenic stimulation, and vascular endothelial growth factor (VEGF), a signal protein produced by cells that stimulate the growth of blood vessels. Both proteins play an important role in tumor growth and metastases as well as angiogenesis (growth of new blood vessels). FVIIa/TF complex also initiates the coagulation (a process by which blood forms clots) processes implicated in the high incidence of thromboembolic (the process by which the blood clots within a blood vessel) complications seen in patients with TF-expressing cancers. Thromboembolic events are a cause of death in patients with cancer and anticoagulant treatment has been shown to improve survival in a variety of cancers (Klerk et al. JCO. 2005).
PCI-27483 Factor VIIa Inhibitor
The Company�� Factor VIIa inhibitor PCI-27483 is a first-in-human small molecule inhibitor that selectively targets FVIIa. As an inhibitor of FVIIa, PCI-27483 has two potential mechanisms of action: inhibition of intracellular signaling involved in tumor growth and metastases and inhibition of early coagulation processes associated with thromboembolism.
Factor VIIa PCI-27483 Clinical Development Update
A multicenter Phase I/II of PCI-27483 in patients with locally a! dvanced o! r metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). The objectives are to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Due to a paradigm shift away from the use of gemcitabine alone for the treatment of pancreatic cancer, enrolling patients in this randomized study has been challenging. PCYC is evaluating other alternatives for development of this agent.
A multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). PCI-27483 is covered by United States patents and patent applications and counterpart patents and patent applications in fourteen ex-United States territories, including Europe, Canada, Mexico, Japan, China, India, South Korea, Australia and Brazil.
Advisors' Opinion:- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
- [By Jon C. Ogg]
Pharmacyclics Inc. (NASDAQ: PCYC) was started as Overweight with a $142 price target at J.P. Morgan. Deutsche Bank also started it with a Buy rating and a $170 price target.
- [By John Udovich]
Bubble talk, biotech IPO setbacks plus news�about small cap biotechs like Intrexon Corp (NYSE: XON) and TNI BioTech (OTCMKTS: TNIB) have dominated biotech news this week or in recent weeks. Just consider the following news:
Why There is No Biotech Bubble & Where to Look for Value in Biotech. Marshall Gordon, the Director and senior health-care analyst of ClearBridge Investments, was recently interviewed by Barron�� where he stated his belief that there is no biotech bubble because biotech stocks have delivered new drugs and have shown an ability to innovate. With that said, he added that the sector got ahead of itself while some biotechs suffered setbacks plus hedge funds decided to trim risk from their portfolios. Nevertheless, Marshall likes or is watching mid cap biotechs BioMarin Pharmaceutical Inc (NASDAQ: BMRN) and Pharmacyclics, Inc (NASDAQ: PCYC) along with small cap biotechs�Pacira Pharmaceuticals Inc (NASDAQ: PCRX) and Clovis Oncology Inc (NASDAQ: CLVS). He also added that recent biotech IPOs have been lesser quality names than earlier offerings. A Trio of Biotech�IPO Setbacks. FierceBiotech has�summarized how a trio of biotech IPO have suffered setbacks. Specifically, Relypsa (NASDAQ: RLYP), a late-stage biotech developing a treatment for hyperkalemia,�slashed its asking price on 6.9 million shares to $12 a share to raise $82 million�from a range of $16 to $19 a share while�Xencor (NASDAQ: XNCR), a biotech developing antibodies for severe autoimmune/allergic diseases and cancer,�has dropped its IPO price to $7 a share to raise $75 million from a range of $14 to $16. Meanwhile, Celladon, which is developing a first-in-class gene therapy for patients with systolic heart failure, has postponed its IPO citing poor market conditions. Coming�Biotech IPOs. Nevertheless, FierceBiotech has noted that GeNO Healthcare (NASDAQ: GNO) is looking to raise $50 million for its�new, patient-friendly approach for delivering inhaled nitric oxide on the - [By John McCamant]
The company��hich we consider conservative among biotech stocks��s Pharmacyclics (PCYC). Its pill is also expected to be approved for a much larger B-cell cancer market, chronic lymphocytic leukemia (CLL), by the end of February.
Top Clean Energy Stocks To Own For 2014: Ulta Salon Cosmetics and Fragrance Inc (ULTA)
Ulta Salon, Cosmetics & Fragrance, Inc. (Ulta), incorporated on January 9, 1990, is a beauty retailer, which provides one-stop shopping for prestige, mass and salon products and salon services in the United States. During the year ended January 28, 2012 (fiscal 2011), the Company opened 61 new stores. It operates full-service salons in all of its stores. Its Ulta store format includes an open and modern salon area with approximately eight to 10 stations. The entire salon area is approximately 950 square feet with a concierge desk, skin treatment room, semi-private shampoo and hair color processing areas. Each salon is a full-service salon offering hair cuts, hair coloring and permanent texture, with salons also providing facials and waxing.
The Company offers products in the categories, such as cosmetics, which includes products for the face, eyes, cheeks, lips and nails; haircare, which includes shampoos, conditioners, styling products, and hair accessories; salon styling tools, which includes hair dryers, curling irons and flat irons; skincare and bath and body, which includes products for the face, hands and body; fragrance for both men and women; private label, consisting of Ulta branded cosmetics, skincare, bath and body products and haircare, and other, including candles, home fragrance products and other miscellaneous health and beauty products. The Company has combined its three operating segments: retail stores, salon services and e-commerce, into one reportable segment.
The Company competes with Macy��, Nordstrom, Sephora, Bath & Body Works, CVS/pharmacy, Walgreens, Target, Wal-Mart, Regis Corp., Sally Beauty and JCPenney salons.
Advisors' Opinion:- [By Lisa Levin]
Ulta Salon, Cosmetics & Fragrance (NASDAQ: ULTA) shares rose 7.73% to $96.43. The volume of Ulta Salon shares traded was 708% higher than normal. Ulta Salon reported better-than-expected fourth-quarter earnings. Ulta Salon posted its quarterly earnings of $1.09 per share, beating analysts' estimates of $1.07 per share.
Top Clean Energy Stocks To Own For 2014: Royal Dutch Shell PLC (RDSB)
Royal Dutch Shell plc (Shell), incorporated on February 5, 2002, is an independent oil and gas company. The Company owns, directly or indirectly, investments in the numerous companies constituting Shell. Shell is engaged worldwide in the principal aspects of the oil and gas industry and also has interests in chemicals and other energy-related businesses. The Company operates in three segments: Upstream, Downstream and Corporate. Upstream combines the operating segments Upstream International and Upstream Americas, which are engaged in searching for and recovering crude oil and natural gas; the liquefaction and transportation of gas; the extraction of bitumen from oil sands that is converted into synthetic crude oil, and wind energy. Downstream is engaged in manufacturing; distribution and marketing activities for oil products and chemicals, in alternative energy (excluding wind), and carbon dioxide (CO2) management. Corporate represents the key support functions, comprising holdings and treasury, headquarters, central functions and Shell�� self-insurance activities. In October 2011, the Company bought a marine terminal on Canada's Pacific Coast as a possible site for a liquefied natural gas export terminal. In January 2012, the Company's 50% owned, Australia Arrow Energy Holdings Pty Ltd acquired all of the shares in Bow Energy Ltd. In January 2014, Royal Dutch Shell plc completed the acquisition of Repsol S.A.'s liquefied natural gas (LNG) portfolio outside North America.
Upstream International manages the Upstream businesses outside the Americas. It searches for and recovers crude oil and natural gas, liquefies and transports gas, and operates the upstream and midstream infrastructure necessary to deliver oil and gas to market. Upstream International also manages Shell�� entire liquefied petroleum gas (LNG) business, gas to liquids (GTL) and the wind business in Europe. Its activities are organized primarily within geographical units, although there are some activities that are mana! ged across the businesses or provided through support units.
Upstream Americas manages the Upstream businesses in North and South America. It searches for and recovers crude oil and natural gas, transports gas and operates the upstream and midstream infrastructure necessary to deliver oil and gas to market. Upstream Americas also extracts bitumen from oil sands that is converted into synthetic crude oil. Additionally, it manages the United States-based wind business. It comprises operations organized into business-wide managed activities and supporting activities.
Downstream manages Shell�� manufacturing, distribution and marketing activities for oil products and chemicals. These activities are organized into globally managed classes of business, although some are managed regionally or provided through support units. Manufacturing and supply includes refining, supply and shipping of crude oil. Marketing sells a range of products including fuels, lubricants, bitumen and liquefied petroleum gas (LPG) for home, transport and industrial use. Chemicals produces and markets petrochemicals for industrial customers, including the raw materials for plastics, coatings and detergents. Downstream also trades Shell�� flow of hydrocarbons and other energy-related products, supplies the Downstream businesses, markets gas and power and provides shipping services. Downstream additionally oversees Shell�� interests in alternative energy (including biofuels, and excluding wind) and CO2 management.
Projects and Technology manages the delivery of Shell�� major projects and drives the research and innovation to create technology solutions. It provides technical services and technology capability covering both Upstream and Downstream activities. It is also responsible for providing functional leadership across Shell in the areas of health, safety and environment, and contracting and procurement.
Advisors' Opinion:- [By Jim Jubak]
But, to my mind, the biggest news of last week for the valuation of Cheniere actually came from Royal Dutch Shell (RDSB). Europe's biggest oil company announced that it would halt plans to build a $20 billion natural gas of liquids plant in Louisiana, even though the state of Louisiana had agreed on $112 million in subsidies. The project would have used cheap US natural gas to produce 140,000 barrels a day of liquid fuels normally made from oil. Royal Dutch Shell cited rising costs and uncertainty about oil and natural gas prices by the time the plant entered operation, in canceling the project.
Top Clean Energy Stocks To Own For 2014: BG Medicine Inc.(BGMD)
BG Medicine, Inc., a life sciences company, engages in the discovery, development, and commercialization of diagnostic tests based on biomarkers in the United States. Its product pipeline includes BGM Galectin-3, a diagnostic test for heart failure that measures galectin-3 levels in blood plasma or serum; AMIPredict, a multivariate biomarker blood-based test for atherothrombotic cardiovascular disease; and LipidDx, a blood-based protein assay for the management of patients with lipid disorders. The company also offers TNF alpha blockers comprising Enbrel, Remicade and Humira, which are treatments indicated for autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn?s disease. It has strategic collaborations and initiatives with pharmaceutical companies and other healthcare organizations, including Abbott Laboratories; ACS Biomarker B.V.; Humana Inc.; Merck & Co., Inc.; and Laboratory Corporation of America. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Roberto Pedone]
Another stock that's starting to move within range of triggering a big breakout trade is BG Medicine (BGMD), which develops and commercializes novel cardiovascular diagnostic tests to address unmet medical needs in the U.S. This stock has been pushed lower by the sellers over the last three months, with shares down sharply by 20%.
If you take a glance at the chart for BG Medicine, you'll notice that this stock has been uptrending a bit for the last month, with shares moving higher from its low of 90 cents per share to its recent high of $1.12 a share. During that uptrend, shares of BGMD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BGMD within range of triggering a big breakout trade above some key near-term overhead resistance levels.
Traders should now look for long-biased trades in BGMD if it manages to break out above some near-term overhead resistance levels at $1.08 to $1.12 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.56 million shares. If that breakout gets started soon, then BGMD will set up to re-fill some of its previous gap-down-day zone from May that started near $1.30 a share. Any high-volume move above $1.30 will then give BGMD a chance to tag its next major overhead resistance levels at $1.50 to around $1.70 a share.
Traders can look to buy BGMD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 96 cents to 90 cents per share. One can also buy BGMD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By James E. Brumley]
What do BG Medicine, Inc. (NASDAQ:BGMD) and Pentair, Ltd. (NYSE:PNR) have in common? Most investors would say absolutely nothing. BGMD is a small cap medical diagnostics company, while PNR is a large cap industrial equipment manufacturer. Those are worlds that simply never collide. The directions each stock has been traveling in over the past few months have even been polar opposites.
Top Clean Energy Stocks To Own For 2014: Baytex Energy Corp (BTE)
Baytex Energy Corp. (Baytex), incorporated on October 22, 2010, through its subsidiaries, are engaged in the business of acquiring, developing, exploiting and holding interests in petroleum and natural gas properties and related assets in Canada (in the provinces of British Columbia, Alberta and Saskatchewan) and in the United States (in the states of North Dakota and Wyoming). The Company acts as the financing vehicle for its subsidiaries by providing access to debt and equity capital markets. As of December 31, 2011, its primary assets are Baytex Energy Ltd. (Baytex Energy), which it owns. On February 3, 2011, the Company acquired heavy oil assets located in the Reno area of northern Alberta and the Lloydminster area of western Saskatchewan. On August 9, 2011, the Company acquired natural gas assets located in the Brewster area of west central Alberta. During the year ended December 31, 2011, it completed two dispositions of undeveloped lands; in the Kaybob South area of west central Alberta, it sold six sections of leasehold, including five sections with Duvernay rights, and in the Dodsland area in southwest Saskatchewan, it sold 32,600 net acres of leasehold in the halo of the field.
During 2011, the Company�� production averaged 50,132 barrel of oil equivalent per day, from its properties in Canada. During 2011, production averaged 50,132 barrel of oil equivalent per day. During 2011, light oil and natural gas liquid (NGL) production was 6,769 barrels per day. During 2011, heavy oil production was 35,252 barrels per day. During 2011, natural gas production was 48.7 million cubic feet per day. Its crude oil and natural gas operations are organized into three business units: Alberta/B.C., Saskatchewan and United States. Each business unit has a portfolio of mineral leases, operated and non-operated properties and development prospects. These plays include the Bakken/Three Forks in the Williston Basin of North Dakota and southeast Saskatchewan and the Viking in southwestern Saskatche! wan and eastern Alberta.
Saskatchewan Business Unit
As of December 31, 2011, the Saskatchewan Business Unit accounted for more than 38% of production. The Saskatchewan Business Unit's heavy oil operations include cold primary and thermal (steam-assisted gravity drainage) production. Production is generated from vertical, slant and horizontal wells using progressive cavity pumps capable of handling heavy oil combined with gas, water and sand. Once produced, the oil is delivered to markets in both Canada and the United States on pipelines, tanker trucks or railways. Heavy crude is blended with light-hydrocarbon diluents (such as condensate) prior to being introduced into a sales pipeline. The blended crude oil is then sold by Baytex. During 2011, production in the Saskatchewan Business Unit averaged approximately 20,958 barrels of oil equivalent per day, which was comprised of 19,828 barrels per day of heavy oil, 154 barrels per day of light oil and 5,860 thousand cubic feet per day of natural gas. During 2011, Baytex drilled 93 (87.9 net) wells in the Saskatchewan Business Unit resulting in 84 (78.9 net) oil wells, four stratigraphic test wells, four service wells, and one dry and abandoned well.
The Company�� Ardmore, Alberta is developed in the Sparky, McLaren and Colony formations. During 2011, average production was approximately 652 barrels per day of heavy oil and 158 thousand cubic feet per day of natural gas. During 2011, one well was drilled. As of December 31, 2011, Baytex had 34,000 net undeveloped acres in this area. Its Carruthers property consists of separate North and South oil pools in the Cummings formation. During 2011, 13 wells were drilled. During 2011, average production was approximately 2,444 barrels per day of heavy oil and 489 thousand cubic feet per day of natural gas. As of December 31, 2011, Baytex had 10,600 net undeveloped acres in this area. During 2011, the Company�� Celtic, Saskatchewan producing property produced averaged 3,013 ! barrels p! er day of heavy oil and 538 thousand cubic feet per day of natural gas. During 2011, Baytex drilled seven oil wells in the area. The Company�� Cold Lake, Alberta is a heavy oil property. Production is from the Colony, Upper McLaren, Rex and Sparky formations. During 2011, average oil production was approximately 270 barrels per day. During 2011, Baytex had 11,300 net undeveloped acres in this area.
During 2011, in Kerrobert SAGD project, the Company placed two new well pairs on production. During 2011, average production from the Kerrobert area was approximately 3,350 barrels per day of heavy oil, 154 barrels per day of light oil, and 1,999 thousand cubic feet per day of natural gas. During 2011, Baytex drilled five oil wells and eight service wells in this area. As of December 31, 2011, Baytex had 38,600 net undeveloped acres in this area. Lindbergh is a non-operated heavy oil property. Baytex has a 21.25% working interest in this property. During 2011, average production in this area was approximately 673 barrels per day of heavy oil and 71 thousand cubic feet per day of natural gas. During 2011, four wells were drilled in this area. As of December 31, 2011, Baytex had 800 net undeveloped acres in this area. During 2011, its Marsden/Epping/Macklin/Silverdale, Saskatchewan produced approximately 2,102 barrels per day of oil and 290 thousand cubic feet per day of natural gas. During 2011, nine oil wells were drilled in this area. Its Tangleflags is characterized by multiple-zone reservoirs with production from the Colony, McLaren, Waseca, Sparky, General Petroleum and Lloydminster formations. During 2011, Baytex drilled 11 horizontal oil wells in the Lloydminster formation. During 2011, average production was approximately 1,763 barrels per day of heavy oil and 543 thousand cubic feet per day of natural gas.
Alberta/B.C. Business Unit
The Alberta/B.C. Business Unit possesses a range of light oil, heavy oil and natural gas properties. During 2011, the Alberta/B.C.! Business! Unit produced light and heavy gravity crude oil, natural gas, and natural gas liquids from fields in Alberta and British Columbia and accounted for approximately 58% of production. During 2011, production from this business unit averaged 27,833 barrel of oil equivalent per day, which was comprised of 15,425 barrels per day of heavy oil, 5,282 barrels per day of light oil and NGL and 42.8 million cubic feet per day of natural gas. During 2011, the Alberta/B.C. Business Unit participated in the drilling of 71 wells resulting in 61 oil wells, one natural gas well, seven stratigraphic test wells, one service well and one dry and abandoned well. As of December 31, 2011, its net undeveloped lands in this business unit totaled approximately 474,000 acres. During 2011, production from Bon Accord area was averaged approximately 905 barrels per day of light oil and 1,742 million cubic feet per day of natural gas. Natural gas is processed at two Baytex-operated plants and oil is treated at three Baytex-operated batteries. During 2011, in this area, Baytex drilled 11 horizontal Viking oil wells. As of December 31, 2011, Baytex had 18,300 net undeveloped acres in this area.
The Company�� Darwin/Nina/Goodfish/Lafond, Alberta produces natural gas from the Bluesky formation. During 2011, production averaged approximately 3,746 million cubic feet per day of natural gas. As of December 31, 2011, Baytex had 27,300 net undeveloped acres in this area. During 2011, the Company�� Leahurst, Alberta produced averaged approximately 2,633 million cubic feet per day of natural gas and 13 barrels per day of NGL from this multi-zone, year-round access area. Natural gas production from the Edmonton, Belly River, Viking and Mannville formations is processed. Baytex holds a total of 263 net sections of oil sands leases in the Peace River oil sands area, which includes the legacy Seal area and the Reno area. During 2011, production from the Peace River area was 15,425 barrels per day, which was comprised of 13,746 barr! els per d! ay from Seal and 1,679 barrels per day from Reno. During 2011, Baytex drilled 25 cold horizontal production wells and seven stratigraphic test wells at Seal and two cold horizontal production wells at Reno. The Peace River area includes 152,500 net undeveloped acres, including 57,000 net undeveloped acres at Seal and 95,500 net undeveloped acres at Reno.
During 2011, the Company�� Pembina production averaged 2,633 barrels per day of light oil and NGL and 22,428 million cubic feet per day of natural gas. During 2011, Baytex participated in drilling 19 wells in this area, resulting in 17 oil wells, one natural gas well, and one dry and abandoned well. During 2011, Pembina area drilling included five operated and 12 non-operated Cardium horizontal wells and completed with multi-stage fracture stimulations. During 2011, the Company�� production from Red Earth area averaged approximately 42 million cubic feet per day of natural gas and 522 barrels per day of light oil and NGL. During 2011, the Company�� Richdale/Sedalia property�� production averaged approximately 3,845 million cubic feet per day of natural gas and eight barrels per day of NGL. During 2011, the Company�� production from Stoddart area averaged approximately 4,498 million cubic feet per day of natural gas and 713 barrels per day of oil and NGL. During 2011, production from Turin was averaged approximately 345 barrels per day of oil and NGL and 856 million cubic feet per day of natural gas. Production is from the Second White Specks, Milk River, Bow Island, Mannville, Sawtooth and Livingstone formations.
United States Business Unit
During 2011, the Company focused its activities on the light oil resource play located in the Divide and Williams Counties of North Dakota. Production is from horizontal wells using multi-stage hydraulic fracturing in the Bakken and Three Forks formations. As of December 31, 2011, Baytex owned approximately 61,000 (24,800 net) developed acres. During 2011, Baytex parti! cipated i! n the drilling of 34 Bakken/Three Forks oil wells. During 2011, net production from the United States properties averaged 1,341 barrels of oil equivalent per day.
Advisors' Opinion:- [By GURUFOCUS]
Canadian Trusts- Baytex Energy Trust (BTE) | Yield: 6.1%
- Enerplus Resources Fund (ERF) | Yield: 5.6%
- Pengrowth Energy Trust (PGH) | Yield: 7.1% - [By Rich Duprey]
Canadian oil and gas producer�Baytex Energy (NYSE: BTE ) announced yesterday its monthly dividend payment for June of $0.22 Canadian per share, the same monthly rate it's paid since 2011.�The U.S. dollar equivalent is approximately $0.2162 per share, assuming a foreign exchange rate of $0.9826 USD-CAD.
- [By Robert Rapier]
There are a number of quality Canadian E&P companies that are attractive at current prices. Among my favorites are Baytex Energy (NYSE: BTE, TSE: BTE), Cenovus Energy (NYSE: CVE, TSE: CVE) and Canadian Natural Resources (NYSE: CNQ, TSE: CNQ) I also like Peyto Exploration & Development (TSE: PEY, OTC: PEYUF) for aggressive investors. We have often discussed putting Peyto in one of the portfolios, but I would ideally like it a bit cheaper.
- [By Stephan Dube]
Peace River's most notable producers:
PennWest Exploration (PWE), see article here.Royal Dutch Shell (RDS.A), see article here.Baytex (BTE), see article here.Strata Oil and Gas (SOIGF.PK), see article here.Petrobank Energy & Resources (PBEGF.PK), see article here.Cold Lake's most notable producers:
No comments:
Post a Comment